81 FR 83250 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 224 (November 21, 2016)

Page Range		83250-83250
FR Document		2016-27878

Federal Register, Volume 81 Issue 224 (Monday, November 21, 2016)

[Federal Register Volume 81, Number 224 (Monday, November 21, 2016)]
[Notices]
[Page 83250]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-27878]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Multi-site Clinical Trials SEP III.
    Date: December 9, 2016.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Susan O. McGuire, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., 
Room 4245, Rockville, MD 20852, (301) 827-5817, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: November 15, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-27878 Filed 11-18-16; 8:45 am]
 BILLING CODE 4140-01-P

83250 Federal Register / Vol. 81, No. 224 / Monday, November 21, 2016 / Notices

Information pertaining to references and (Catalogue of Federal Domestic Assistance DEPARTMENT OF HEALTH AND
recommendations is obtained from other Program Nos. 93.233, National Center for HUMAN SERVICES
private individuals, educational Sleep Disorders Research; 93.837, Heart and
institutions, current and former Vascular Diseases Research; 93.838, Lung National Institutes of Health
employers, HHS program personnel, Diseases Research; 93.839, Blood Diseases
biographical reference books, private and Resources Research, National Institutes National Heart, Lung, and Blood
of Health, HHS) Institute; Notice of Closed Meeting
organizations, Members of Congress,
and other government sources. Dated: November 15, 2016. Pursuant to section 10(d) of the
EXEMPTIONS CLAIMED FOR THE SYSTEM: Michelle Trout, Federal Advisory Committee Act, as
None. Program Analyst, Office of Federal Advisory amended (5 U.S.C. App.), notice is
Committee Policy. hereby given of the following meeting.
[FR Doc. 2016–27959 Filed 11–18–16; 8:45 am] The meeting will be closed to the
BILLING CODE P
[FR Doc. 2016–27876 Filed 11–18–16; 8:45 am]
public in accordance with the
BILLING CODE 4140–01–P
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
DEPARTMENT OF HEALTH AND as amended. The grant applications and
HUMAN SERVICES DEPARTMENT OF HEALTH AND
HUMAN SERVICES the discussions could disclose
National Institutes of Health confidential trade secrets or commercial
National Institutes of Health property such as patentable material,
National Heart, Lung, and Blood and personal information concerning
Institute; Notice of Closed Meetings National Institute on Drug Abuse; individuals associated with the grant
Notice of Closed Meeting applications, the disclosure of which
Pursuant to section 10(d) of the would constitute a clearly unwarranted
Federal Advisory Committee Act, as Pursuant to section 10(d) of the invasion of personal privacy.
amended (5 U.S.C. App.), notice is Federal Advisory Committee Act, as
hereby given of the following meetings. Name of Committee: Heart, Lung, and
amended (5 U.S.C. App), notice is Blood Initial Review Group, NHLBI
The meetings will be closed to the
hereby given of the following meeting. Institutional Training Mechanism Review
public in accordance with the Committee.
provisions set forth in sections The meeting will be closed to the
Date: December 9, 2016.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., public in accordance with the Time: 10:00 a.m. to 4:00 p.m.
as amended. The grant applications and provisions set forth in sections Agenda: To review and evaluate grant
the discussions could disclose 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
confidential trade secrets or commercial as amended. The grant applications and Place: National Institutes of Health, 6701
property such as patentable material, the discussions could disclose Rockledge Drive, Room 7194, Bethesda, MD
and personal information concerning confidential trade secrets or commercial 20892 (Telephone Conference Call).
property such as patentable material, Contact Person: Charles Joyce, Ph.D.,
individuals associated with the grant Scientific Review Officer, Office of Scientific
applications, the disclosure of which and personal information concerning Review/DERA, National Heart, Lung, and
would constitute a clearly unwarranted individuals associated with the grant Blood Institute, 6701 Rockledge Drive, Room
invasion of personal privacy. applications, the disclosure of which 7194, Bethesda, MD 20892–7924, 301–435–
Name of Committee: National Heart, Lung,
would constitute a clearly unwarranted 0288, cjoyce@nhlbi.nih.gov.
and Blood Institute Special Emphasis Panel; invasion of personal privacy. (Catalogue of Federal Domestic Assistance
Human Virome in Heart, Lung, and Blood Name of Committee: National Institute on Program Nos. 93.233, National Center for
Health and Resilience. Drug Abuse Special Emphasis Panel, Multi- Sleep Disorders Research; 93.837, Heart and
Date: December 9, 2016. Vascular Diseases Research; 93.838, Lung
site Clinical Trials SEP III.
Time: 8:30 a.m. to 5:00 p.m. Diseases Research; 93.839, Blood Diseases
Date: December 9, 2016. and Resources Research, National Institutes
Agenda: To review and evaluate grant Time: 1:00 p.m. to 3:00 p.m.
applications. of Health, HHS)
Agenda: To review and evaluate grant
Place: Residence Inn Bethesda, 7335 Dated: November 15, 2016.
applications.
Wisconsin Avenue, Bethesda, MD 20814.
Place: National Institutes of Health, Michelle Trout,
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific Neuroscience Center, 6001 Executive Program Analyst, Office of Federal Advisory
Review/DERA National Heart, Lung, and Boulevard, Rockville, MD 20852 (Telephone Committee Policy.
Blood Institute, 6701 Rockledge Drive, Room Conference Call). [FR Doc. 2016–27875 Filed 11–18–16; 8:45 am]
7185, Bethesda, MD 20892, 301–496–2434, Contact Person: Susan O. McGuire, Ph.D., BILLING CODE 4140–01–P
kristen.page@nih.gov. Scientific Review Officer, Office of
Name of Committee: National Heart, Lung, Extramural Affairs, National Institute on
and Blood Institute Special Emphasis Panel; Drug Abuse, National Institutes of Health,
DEPARTMENT OF HEALTH AND
T32—Training Programs for Institutions that DHHS, 6001 Executive Blvd., Room 4245,
HUMAN SERVICES
Promote Diversity. Rockville, MD 20852, (301) 827–5817,
Date: December 9, 2016. mcguireso@mail.nih.gov.
National Institutes of Health
Time: 11:00 a.m. to 12:00 p.m. (Catalogue of Federal Domestic Assistance
Agenda: To review and evaluate grant Program Nos.: 93.279, Drug Abuse and Center for Scientific Review; Notice of
asabaliauskas on DSK3SPTVN1PROD with NOTICES

applications. Addiction Research Programs, National
Place: National Institutes of Health, 6701
Closed Meetings
Institutes of Health, HHS)
Rockledge Drive, Room 7189, Bethesda, MD Pursuant to section 10(d) of the
20892 (Telephone Conference Call). Dated: November 15, 2016.
Federal Advisory Committee Act, as
Contact Person: Stephanie L. Constant, Natasha M. Copeland,
Ph.D., Scientific Review Officer, Office of
amended (5 U.S.C. App.), notice is
Program Analyst, Office of Federal Advisory hereby given of the following meetings.
Scientific Review/DERA National Heart,
Committee Policy. The meetings will be closed to the
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7189, Bethesda, MD 20892, 301– [FR Doc. 2016–27878 Filed 11–18–16; 8:45 am] public in accordance with the
443–8784, constantsl@nhlbi.nih.gov. BILLING CODE 4140–01–P provisions set forth in sections

VerDate Sep<11>2014 18:09 Nov 18, 2016 Jkt 241001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\21NON1.SGM 21NON1

Document Created: 2018-02-14 08:34:12
Document Modified: 2018-02-14 08:34:12

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		December 9, 2016.
FR Citation		81 FR 83250

81 FR 83250 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 224 (November 21, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health